MAHON PAUL A
SEC CIK 1231589 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | EVP, GC | 53.5K | — | $246.06M | 232 | 2021-07-01 | 2026-09-17 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $840.04M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 232
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-18 16:40 | 2026-09-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-09-18 16:40 | 2026-09-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $497.54 | -8,300 | 45.2K | -16% | -$4.13M |
| DT | 2026-09-03 16:32 | 2026-09-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-09-03 16:32 | 2026-09-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $482.03 | -8,300 | 45.2K | -16% | -$4.00M |
| DMT | 2026-08-21 16:43 | 2026-08-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-08-21 16:43 | 2026-08-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $523.14 | -8,300 | 45.2K | -16% | -$4.34M |
| DT | 2026-08-06 16:35 | 2026-08-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-08-06 16:35 | 2026-08-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $517.05 | -8,300 | 45.2K | -16% | -$4.29M |
| DT | 2026-07-16 16:30 | 2026-07-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-07-16 16:30 | 2026-07-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $533.69 | -8,300 | 45.2K | -16% | -$4.43M |
| DT | 2026-07-02 16:32 | 2026-07-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-07-02 16:32 | 2026-07-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $552.56 | -8,300 | 45.2K | -16% | -$4.59M |
| DT | 2026-06-18 16:31 | 2026-06-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-06-18 16:31 | 2026-06-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $541.55 | -8,300 | 45.2K | -16% | -$4.49M |
| DT | 2026-06-04 17:30 | 2026-06-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-06-04 17:30 | 2026-06-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $547.07 | -8,300 | 45.2K | -16% | -$4.54M |
| DMT | 2026-05-21 16:33 | 2026-05-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-05-21 16:33 | 2026-05-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $562.82 | -8,300 | 45.2K | -16% | -$4.67M |
| DT | 2026-05-07 16:31 | 2026-05-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-05-07 16:31 | 2026-05-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $586.75 | -8,300 | 45.2K | -16% | -$4.87M |
| DT | 2026-04-16 16:30 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-04-16 16:30 | 2026-04-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $576.82 | -8,300 | 45.2K | -16% | -$4.79M |
| DT | 2026-04-02 16:36 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-04-02 16:36 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $565.87 | -8,300 | 45.2K | -16% | -$4.70M |
| DT | 2026-03-19 | 2026-03-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-03-19 | 2026-03-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $529.95 | -8,300 | 45.2K | -16% | -$4.40M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | F - Tax | $536.12 | -8,363 | 49.1K | -15% | -$4.48M |
| DM | 2026-03-17 | 2026-03-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | — | +16.7K | 45.7K | +57% | — |
| DMT | 2026-03-05 | 2026-03-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $483.15 | -8,300 | 40.2K | -17% | -$4.01M |
| DT | 2026-03-05 | 2026-03-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DMT | 2026-02-19 | 2026-02-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $476.34 | -8,300 | 44.5K | -16% | -$3.95M |
| DT | 2026-02-19 | 2026-02-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DMT | 2026-02-05 | 2026-02-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $483.24 | -8,300 | 36.8K | -18% | -$4.01M |
| DT | 2026-02-05 | 2026-02-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DMT | 2026-01-15 | 2026-01-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $469.89 | -8,300 | 42.3K | -16% | -$3.90M |
| DT | 2026-01-15 | 2026-01-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DMT | 2026-01-02 | 2026-01-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $485.43 | -8,300 | 43.0K | -16% | -$4.03M |
| DT | 2026-01-02 | 2026-01-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 45.1K | +23% | +$1.21M |
| DT | 2025-12-29 | 2025-12-24 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +11.0K | 47.8K | +30% | +$1.61M |
| DMT | 2025-12-29 | 2025-12-24 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $513.18 | -11.0K | 36.8K | -23% | -$5.64M |
| DT | 2025-12-12 | 2025-12-11 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +11.0K | 47.8K | +30% | +$1.61M |
| DMT | 2025-12-12 | 2025-12-11 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $484.67 | -11.0K | 38.3K | -22% | -$5.33M |
| DMT | 2025-11-26 | 2025-11-26 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $486.07 | -11.0K | 45.5K | -19% | -$5.35M |
| DT | 2025-11-26 | 2025-11-26 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-11-13 | 2025-11-13 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $464.76 | -11.0K | 42.5K | -21% | -$5.11M |
| DT | 2025-11-13 | 2025-11-13 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-10-30 | 2025-10-30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $450.34 | -11.0K | 47.1K | -19% | -$4.95M |
| DT | 2025-10-30 | 2025-10-30 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-10-20 | 2025-10-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-10-20 | 2025-10-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $431.50 | -11.0K | 41.3K | -21% | -$4.75M |
| DMT | 2025-10-02 | 2025-10-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $436.60 | -11.0K | 46.4K | -19% | -$4.80M |
| DT | 2025-10-02 | 2025-10-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-09-18 | 2025-09-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $406.17 | -11.0K | 38.0K | -22% | -$4.47M |
| DT | 2025-09-18 | 2025-09-18 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-09-05 | 2025-09-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $385.21 | -11.0K | 39.3K | -22% | -$4.24M |
| DT | 2025-09-05 | 2025-09-04 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-08-22 | 2025-08-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $308.75 | -11.0K | 43.1K | -20% | -$3.40M |
| DT | 2025-08-22 | 2025-08-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-08-08 | 2025-08-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-08-08 | 2025-08-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $300.00 | -11.0K | 46.4K | -19% | -$3.30M |
| DMT | 2025-07-25 | 2025-07-24 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $304.11 | -11.0K | 39.0K | -22% | -$3.35M |
| DT | 2025-07-25 | 2025-07-24 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-07-14 | 2025-07-10 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-07-14 | 2025-07-10 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $300.31 | -11.0K | 45.9K | -19% | -$3.30M |
| DMT | 2025-06-27 | 2025-06-26 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $285.70 | -11.0K | 41.3K | -21% | -$3.14M |
| DT | 2025-06-27 | 2025-06-26 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-06-16 | 2025-06-12 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $279.96 | -11.0K | 41.5K | -21% | -$3.08M |
| DT | 2025-06-16 | 2025-06-12 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DMT | 2025-05-30 | 2025-05-29 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $316.07 | -11.0K | 41.9K | -21% | -$3.48M |
| DMT | 2025-05-30 | 2025-05-29 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $129.00 | +11.0K | 47.8K | +30% | +$1.42M |
| DMT | 2025-05-20 | 2025-05-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $295.10 | -11.0K | 36.8K | -23% | -$3.25M |
| DT | 2025-05-20 | 2025-05-15 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +11.0K | 47.8K | +30% | +$1.30M |
| DT | 2025-05-02 | 2025-05-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +11.0K | 47.8K | +30% | +$1.30M |
| DMT | 2025-05-02 | 2025-05-01 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $300.93 | -11.0K | 46.0K | -19% | -$3.31M |
| DT | 2025-04-18 | 2025-04-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +11.0K | 47.8K | +30% | +$1.30M |
| DMT | 2025-04-18 | 2025-04-17 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $283.78 | -11.0K | 39.9K | -22% | -$3.12M |
| DMT | 2025-04-07 | 2025-04-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $306.18 | -11.0K | 42.1K | -21% | -$3.37M |
| DT | 2025-04-07 | 2025-04-03 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $117.76 | +11.0K | 47.8K | +30% | +$1.30M |
| DT | 2025-03-07 | 2025-03-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +6,550 | 43.3K | +18% | +$1.07M |
| DT | 2025-03-07 | 2025-03-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $307.68 | -6,550 | 36.8K | -15% | -$2.02M |
| DT | 2025-02-21 | 2025-02-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2025-02-21 | 2025-02-20 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $367.36 | -7,700 | 36.7K | -17% | -$2.83M |
| DT | 2025-02-10 | 2025-02-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $353.75 | -7,700 | 36.7K | -17% | -$2.72M |
| DT | 2025-02-10 | 2025-02-06 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2025-01-17 | 2025-01-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $366.39 | -7,700 | 36.7K | -17% | -$2.82M |
| DT | 2025-01-17 | 2025-01-16 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2025-01-03 | 2025-01-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2025-01-03 | 2025-01-02 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $360.22 | -7,700 | 36.7K | -17% | -$2.77M |
| DT | 2024-12-20 | 2024-12-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2024-12-20 | 2024-12-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $360.16 | -7,700 | 36.7K | -17% | -$2.77M |
| DT | 2024-12-06 | 2024-12-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $374.37 | -7,700 | 36.7K | -17% | -$2.88M |
| DT | 2024-12-06 | 2024-12-05 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| DT | 2024-11-22 | 2024-11-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | S - Sale+OE | $367.36 | -7,700 | 36.7K | -17% | -$2.83M |
| DT | 2024-11-22 | 2024-11-21 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| D | 2024-11-08 | 2024-11-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| D | 2024-11-08 | 2024-11-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $402.57 | -7,700 | 36.7K | -17% | -$3.10M |
| DM | 2024-10-18 | 2024-10-03+ | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $361.44 | -15.4K | 36.7K | -30% | -$5.57M |
| DM | 2024-10-18 | 2024-10-03+ | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +15.4K | 44.4K | +53% | +$2.51M |
| D | 2024-09-23 | 2024-09-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | M - OptEx | $163.30 | +7,700 | 44.4K | +21% | +$1.26M |
| D | 2024-09-23 | 2024-09-19 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | EVP, GC | D - Sale to Iss | $351.33 | -7,700 | 36.7K | -17% | -$2.71M |
Purchase Sale Sale after option exercise All abbreviations